177Lu-rhPSMA-10.1 also demonstrated significant therapeutic efficacy in 2 PCa human xenograft mouse models that compared favorably with that of 177Lu-PSMA-617 and 177Lu-PSMA-I&T. This evidence concerns the gene FOLH1 and posterior cortical atrophy.